Aprea Therapeutics, Inc. - Common Stock (APRE)

Historical Holders from Q1 2023 to Q3 2025

Symbol
APRE on Nasdaq
CUSIP
03836J201
Type / Class
Equity / Common Stock
Shares outstanding
6.89M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
1.62M
Holdings value
$2.39M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
23
Number of buys
6
Number of sells
-8
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Aprea Therapeutics, Inc. - Common Stock (APRE)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
LYTTON LAURENCE W 9.9% $914K 682K LYTTON LAURENCE W Nov 13, 2025
Nantahala Capital Management, LLC 7.3% $840K 412K Nantahala Capital Management, LLC Sep 30, 2024
Stonepine Capital Management, LLC 4.3% -16% $488K -$95.8K 239K -16.4% Stonepine Capital Management, LLC Mar 31, 2025
Sio Capital Management, LLC 1.93% -62.4% $166K -$247K 112K -59.8% Sio Capital Management, LLC Sep 30, 2025

Institutional Holders of Aprea Therapeutics, Inc. - Common Stock (APRE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 1.62M $2.39M -$296K $1.48 23
2025 Q2 1.82M $3.07M -$77.6K $1.69 23
2025 Q1 1.85M $3.77M -$166K $2.04 25
2024 Q4 2.08M $6.83M +$211K $3.29 26
2024 Q3 2M $5.5M -$431K $2.75 20
2024 Q2 2.08M $8.47M +$1.87M $4.07 26
2024 Q1 1.62M $10.8M +$4.9M $6.69 21
2023 Q4 806 $3.79K $4.70 1
2023 Q3 876K $3.66M -$18.5K $4.17 20
2023 Q2 881K $2.77M +$102K $3.15 17
2023 Q1 848K $3.77M +$3.77M $4.44 16